Identification of tumour-associated T-cell epitopes for vaccine development.
about
Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastropheCancer/testis antigens and gametogenesis: a review and "brain-storming" sessionImproving the clinical impact of biomaterials in cancer immunotherapy.Using protein microarray as a diagnostic assay for non-small cell lung cancerAutoantibodies as potential biomarkers for breast cancer.Phase 1 study of OCV-C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer.Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome.Neem leaf preparation enhances Th1 type immune response and anti-tumor immunity against breast tumor associated antigen.Profound tumor-specific Th2 bias in patients with malignant glioma.VaccImm: simulating peptide vaccination in cancer therapy.Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer.The future of vaccination as a treatment strategy in dermatological diseases.Novel therapeutic agents under investigation for malignant melanoma.Targeted cancer therapy with gonadotropin-releasing hormone chimeric proteins.T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?New and emerging vaccination strategies for prevention and treatment of dermatological diseases.Poor correlation between T-cell activation assays and HLA-DR binding prediction algorithms in an immunogenic fragment of Pseudomonas exotoxin A.Targeted drug delivery in cancer therapy.Synthesis of novel cyclic NGR/RGD peptide analogs via on resin click chemistry.Some considerations on the use of peptides and mRNA for therapeutic vaccination against cancer.The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigensRedirecting adaptive immunity against foreign antigens to tumors for cancer therapy.Dendritic cell vaccine strategies for renal cell carcinoma.Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP miceRegulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer.Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapyMHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.T cells as vehicles for cancer vaccinationModulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.The bifacial role of helminths in cancer: involvement of immune and non-immune mechanisms.Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer.Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT.Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.In situ loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunity.A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.
P2860
Q24539125-E145592B-B0E5-4E3E-B412-1FF24DCEF794Q24798047-1F94F593-A0FD-4042-8E6D-B960C3206F77Q26766267-F2CBD287-112D-4475-A319-B5795BF74EB7Q30796772-CE86ED66-6248-4697-A688-F8870114FB75Q33332063-315883A7-6945-4248-8737-255769809F06Q33738883-A7AF2838-2915-482B-9EB8-A0723FD3B185Q33762115-B93E6038-1EE1-4D2B-A3FC-6AD774A99D3DQ34111694-759DE826-7606-485F-9867-95B29A5C8D9CQ34491734-1C5F60BA-C216-43F2-8EFD-CCFCCD46F7D1Q34668228-0CC894FA-0E16-4BC2-877D-B10838A83740Q34797653-88F61E8F-F9DA-4F9C-93BC-094F641C17A6Q35015879-6786E5F1-F86C-4330-9A33-544405802600Q35207632-B4597479-AE20-4041-9A4E-32C1B8CC4C46Q35641242-5A2BFB2A-4B90-4F43-A24F-81145A6115DAQ35728607-C2358BA5-AE90-4B66-90D6-6C627F86BCF3Q35843635-0DF1A40E-0149-4F02-993F-B087DFE6CB07Q36157120-2319CE3B-F962-426F-B3B0-F0E30D6EE263Q36200150-803A2A95-FB02-48E0-8D97-E50348B69BF5Q36320557-C5005C7D-ABB9-49AB-8953-56A80FCF9A98Q36471822-7C2B0C86-3B42-4752-A511-2A9D20EC4D27Q36611909-3222429B-4574-455B-A12B-DD8C6CD1A9A1Q36663422-37B4E2C4-6B00-4DB1-9D69-71F7BBCA0141Q36717351-38038BC0-EDE9-47FC-8DA9-7B73551D7040Q36844160-0B130A9D-C74D-4AFF-82C9-6CF561D749D6Q37001690-5F0E96F8-37F7-4826-B483-13BA50A38707Q37652790-15363DF9-12A7-4269-ADED-B032F156E772Q37709626-23A602EA-42A7-46E4-AD72-C5151FFE63B0Q37963343-0D6E719F-9996-4634-BCBA-EE9C3CF3B0BAQ38093572-3057EB62-17A5-40C2-8D83-88B6E520CFDAQ38192723-94C5E1A0-C309-4EC2-83DB-0727B460720EQ38350670-E6195033-8867-4B80-ACC1-52643587026CQ39520906-C871B996-F4AD-4D5E-B326-FCA0E3FC27B3Q40010732-F9794859-6369-468D-A589-595164A187A5Q40104793-CAC49B9D-1E9B-4A26-BB8A-950DC14AAAD8Q42172636-2CE2D1F5-BA40-45B0-86D8-AFA311033F74Q54392858-79932FF5-9469-4F86-9F31-B12E15C290DD
P2860
Identification of tumour-associated T-cell epitopes for vaccine development.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of tumour-associated T-cell epitopes for vaccine development.
@ast
Identification of tumour-associated T-cell epitopes for vaccine development.
@en
Identification of tumour-associated T-cell epitopes for vaccine development.
@nl
type
label
Identification of tumour-associated T-cell epitopes for vaccine development.
@ast
Identification of tumour-associated T-cell epitopes for vaccine development.
@en
Identification of tumour-associated T-cell epitopes for vaccine development.
@nl
prefLabel
Identification of tumour-associated T-cell epitopes for vaccine development.
@ast
Identification of tumour-associated T-cell epitopes for vaccine development.
@en
Identification of tumour-associated T-cell epitopes for vaccine development.
@nl
P356
P1476
Identification of tumour-associated T-cell epitopes for vaccine development.
@en
P2093
Stefan Stevanovic
P2888
P304
P356
10.1038/NRC841
P407
P577
2002-07-01T00:00:00Z
P6179
1011451363